Skip to content

Clinical study on the efficacy and safety of Meizhiquan (ear canal spray dressing) in the treatment of mycotic external auditory canal inflammation

Clinical study on the efficacy and safety of Meizhiquan (ear canal spray dressing) in the treatment of mycotic external auditory canal inflammation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400079625
Enrollment
Unknown
Registered
2024-01-08
Start date
2024-01-08
Completion date
Unknown
Last updated
2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Otolaryngology-related diseases

Interventions

Mild exposure group:None
The Parison exposure group:None
Dycnine exposure group:None
Compound ketoconazole exposure group:None
Fluconazole exposure group:None
Boric acid exposure group:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) patients over 3 years old; 2) diagnose patients with small ear canal wounds caused by fungi; 3) diagnose patients with small ear canal wounds caused by mold; 4) agree and sign the written informed consent

Exclusion criteria

Exclusion criteria: 1) patients with allergic constitution; 2) severe heart, lung, brain, liver and kidney diseases; 3) According to the investigator's judgment, ear canal spray dressing is not suitable for use; 4) patients with mental disorders who cannot cooperate.

Design outcomes

Primary

MeasureTime frame
Smear of fungi;Study drug administration;Background medication administration;Administration of rescue medications;

Secondary

MeasureTime frame
Number of pain;vas score;Rate of recurrence;

Countries

China

Contacts

Public ContactZhao Yu

West China Hospital, Sichuan University

yuzhao@wchscu.edu.cn+86 189 8060 1410

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026